These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27973975)

  • 1. Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection.
    Singh R; Chen J; Miller T; Bergren M; Mallik R
    Pharm Dev Technol; 2018 Dec; 23(10):1024-1029. PubMed ID: 27973975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of Captisol-enabled versus propylene glycol-based melphalan at room temperature and after refrigeration.
    Kawedia JD; Ramchandran S; Liu X; Gulbis AM; Titus M; Bashir Q; Qazilbash MH; Champlin RE; Ciurea SO
    Am J Health Syst Pharm; 2022 Jun; 79(12):1011-1018. PubMed ID: 35176751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.
    Hari P; Aljitawi OS; Arce-Lara C; Nath R; Callander N; Bhat G; Allen LF; Stockerl-Goldstein K
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2100-2105. PubMed ID: 26327631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New injectable melphalan formulations utilizing (SBE)(7m)-beta-CD or HP-beta-CD.
    Ma DQ; Rajewski RA; Stella VJ
    Int J Pharm; 1999 Nov; 189(2):227-34. PubMed ID: 10536251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Propylene Glycol-free Melphalan Conditioning for Hematopoietic Cell Transplantation for Multiple Myeloma and Light Chain Amyloidosis.
    Hari P; Chhabra S
    Transplant Cell Ther; 2022 May; 28(5):242-247. PubMed ID: 35196581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propylene glycol-free melphalan as conditioning regimen for autologous transplantation in myeloma.
    Aljitawi OS; Hari P
    Int J Hematol Oncol; 2016 May; 5(1):5-10. PubMed ID: 30302199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of Melphalan in 0.9% Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection.
    Desmaris RP; Mercier L; Paci A
    Drugs R D; 2015 Sep; 15(3):253-9. PubMed ID: 26178037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a prolonged stability melphalan formulation for intra-arterial treatment of retinoblastoma.
    Jubran JH; Luong H; Naik A; Srinivasan VM; Ramasubramanian A; Li A; Scherschinski L; Feldman MJ; Albuquerque FC; Abruzzo TA
    J Neurointerv Surg; 2024 May; 16(6):572-577. PubMed ID: 37380354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma.
    Hsieh T; Liao A; Francis JH; Lavery JA; Mauguen A; Brodie SE; Abramson DH
    PLoS One; 2020; 15(7):e0235016. PubMed ID: 32609726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II Study of Propylene Glycol-Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
    Cashen AF; Fletcher T; Ceriotti C; Gao F; Ghobadi A; Vij R; Stockerl-Goldstein K; DiPersio J; Abboud C
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2155-2158. PubMed ID: 27575541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of (SBE)7m-beta-CD and HP-beta-CD on the stability of two anti-neoplastic agents, melphalan and carmustine.
    Ma DQ; Rajewski RA; Vander Velde D; Stella VJ
    J Pharm Sci; 2000 Feb; 89(2):275-87. PubMed ID: 10688757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions.
    Zhang YP; Myers AL; Trinh VA; Kawedia JD; Kramer MA; Benjamin RS; Tran HT
    J Oncol Pharm Pract; 2014 Feb; 20(1):58-64. PubMed ID: 23676513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions.
    Kaiser J; Krämer I
    J Oncol Pharm Pract; 2012 Jun; 18(2):213-21. PubMed ID: 22075005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of melphalan solutions during preparation and storage.
    Bosanquet AG
    J Pharm Sci; 1985 Mar; 74(3):348-51. PubMed ID: 4009450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical comparison of intravenous melphalan pharmacokinetics administered in formulations containing either (SBE)7 m-β-cyclodextrin or a co-solvent system.
    Koltun M; Morizzi J; Katneni K; Charman SA; Shackleford DM; McIntosh MP
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):450-4. PubMed ID: 20865695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of melphalan solution for intravitreal injection for retinoblastoma.
    Buitrago E; Lagomarsino E; Mato G; Schaiquevich P
    JAMA Ophthalmol; 2014 Nov; 132(11):1372-3. PubMed ID: 25078631
    [No Abstract]   [Full Text] [Related]  

  • 18. Stability of polymyxin B sulfate diluted in 0.9% sodium chloride injection and stored at 4 or 25 degrees C.
    He J; Figueroa DA; Lim TP; Chow DS; Tam VH
    Am J Health Syst Pharm; 2010 Jul; 67(14):1191-4. PubMed ID: 20592326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature.
    Knoll L; Kraemer I; Thiesen J
    Eur J Hosp Pharm; 2023 Jan; 30(1):11-16. PubMed ID: 33952587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags.
    Gu Z; Wong A; Raquinio E; Nguyen A
    Hosp Pharm; 2015 Jul; 50(7):609-14. PubMed ID: 26448673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.